Thorne HealthTech Inc.

NASDAQ: THRN · Real-Time Price · USD
10.19
-0.01 (-0.10%)
At close: Oct 13, 2023, 10:00 PM

Company Description

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally.

It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions.

The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health.

It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams.

Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

Thorne HealthTech Inc.
Thorne HealthTech Inc. logo
Country United States
IPO Date Sep 23, 2021
Industry Packaged Foods
Sector Consumer Defensive
Employees 544
CEO Paul F. Jacobson

Contact Details

Address:
152 West 57th Street
New York City, New York
United States
Website https://www.thorne.com

Stock Details

Ticker Symbol THRN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001844280
CUSIP Number 885260109
ISIN Number US8852601090
Employer ID 27-2877253
SIC Code 2834

Key Executives

Name Position
Dr. Nathan D. Price Ph.D. Chief Scientific Officer & Chief Executive Officer of Onegevity
Bryan K. Conley Chief Financial Officer
Michelle L. Crow Chief Marketing Officer
Saloni S. Varma Chief Financial Officer & Director
Scott R. Hurth Chief Technology Officer
Thomas P. McKenna Chief Operating Officer & Director
Dr. Bodi Zhang M.D., MPH, Ph.D. Chief Strategy Officer
Kim R. Pearson Gen. Counsel
Rob Monteleone Senior Vice President of Professional Sales
Thomas Wilson Vice President & Head of Investor Relations
William C. McCamy Pres

Latest SEC Filings

Date Type Title
Nov 06, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 26, 2023 15-12G Filing
Oct 18, 2023 4 Filing
Oct 18, 2023 4 Filing
Oct 18, 2023 4 Filing
Oct 18, 2023 4 Filing
Oct 18, 2023 4 Filing
Oct 18, 2023 4 Filing
Oct 18, 2023 4/A [Amend] Filing
Oct 18, 2023 4/A [Amend] Filing